rxstat › Shortages › group 0107304

group 0107304 shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

group 0107304 has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 1
Reports on file
16

Reports by product

Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02362597 · ended Jan 29, 2026 · Disruption of the manufacture of the drug.
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02362597 · ended Jan 29, 2026 · Disruption of the manufacture of the drug.
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02362597 · ended Jan 29, 2026 · Disruption of the manufacture of the drug.
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02362597 · ended Aug 7, 2025 · Disruption of the manufacture of the drug.
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02362597 · ended Oct 28, 2024 · Shortage of an active ingredient.
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02362597 · ended May 13, 2024 · Demand increase for the drug.
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02362597 · ended Dec 1, 2023 · Disruption of the manufacture of the drug.
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02362597 · ended Jun 26, 2023 · Demand increase for the drug.
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02362597 · ended Aug 5, 2022 · Shortage of an inactive ingredient or component.
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02362597 · ended Nov 1, 2022 · Demand increase for the drug.
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LTD
DIN 02362597 · ended Nov 29, 2021 · Other (Please describe in comments)
Resolved
POTASSIUM ACETATE INJECTION USP
39.2% · LIQUID · OMEGA LABORATORIES LTD
DIN 02362597 · ended May 13, 2020 · Disruption of the manufacture of the drug.

Showing 12 of 16 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for group 0107304. Health Canada has 16 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

group 0107304 is classified under “I.V. SOLUTION ADDITIVES” (ATC B05XA).

Recent changes

Common questions

When will group 0107304 be back in stock in Canada?

group 0107304 has no active shortage; supply is normal per Health Canada reports.

Why is group 0107304 in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (i.v. solution additives)

Partial shortageChloride2 of 19 reported products affectedPartial shortageChloride2 of 7 reported products affectedPartial shortageDibasic Monobasic1 of 1 reported products affectedPartial shortageGluconate1 of 2 reported products affectedPartial shortageMagnesium1 of 2 reported products affectedPartial shortageMonobasic1 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.